Spyre Therapeutics, Inc. (SYRE)
104.00
+1.09
(+1.06%)
USD |
NASDAQ |
Nov 13, 16:00
103.00
-1.00
(-0.96%)
Pre-Market: 08:39
Spyre Therapeutics Total Liabilities (Quarterly) : 48.19M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 48.19M |
| June 30, 2026 | 71.86M |
| March 31, 2026 | 93.14M |
| December 31, 2025 | 62.54M |
| September 30, 2025 | 49.50M |
| June 30, 2025 | 83.06M |
| March 31, 2025 | 87.17M |
| December 31, 2024 | 90.68M |
| September 30, 2024 | 93.70M |
| June 30, 2024 | 61.68M |
| March 31, 2024 | 335.33M |
| December 31, 2023 | 157.84M |
| September 30, 2023 | 452.67M |
| June 30, 2023 | 450.90M |
| March 31, 2023 | 18.80M |
| December 31, 2022 | 20.84M |
| September 30, 2022 | 24.01M |
| June 30, 2022 | 22.55M |
| March 31, 2022 | 21.51M |
| December 31, 2021 | 25.98M |
| September 30, 2021 | 26.98M |
| June 30, 2021 | 27.96M |
| March 31, 2021 | 39.86M |
| December 31, 2020 | 21.79M |
| Date | Value |
|---|---|
| September 30, 2020 | 19.36M |
| June 30, 2020 | 20.65M |
| March 31, 2020 | 21.98M |
| December 31, 2019 | 23.10M |
| September 30, 2019 | 20.30M |
| June 30, 2019 | 17.88M |
| March 31, 2019 | 12.23M |
| December 31, 2018 | 10.31M |
| September 30, 2018 | 7.596M |
| June 30, 2018 | 6.266M |
| March 31, 2018 | 5.866M |
| December 31, 2017 | 5.74M |
| September 30, 2017 | 4.994M |
| June 30, 2017 | 4.54M |
| March 31, 2017 | 4.084M |
| December 31, 2016 | 4.097M |
| September 30, 2016 | 3.863M |
| June 30, 2016 | 3.377M |
| March 31, 2016 | 3.842M |
| December 31, 2015 | 2.55M |
| September 30, 2015 | 2.451M |
| June 30, 2015 | 2.738M |
| March 31, 2015 | 1.23M |
| December 31, 2014 | 1.058M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AbbVie, Inc. | 152.22B |
| Incyte Corp. | 1.644B |
| SELLAS Life Sciences Group, Inc. | 9.286M |
| Relay Therapeutics, Inc. | 82.70M |
| ACADIA Pharmaceuticals, Inc. | 406.66M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.100B |
| Shareholders Equity (Quarterly) | 1.052B |
| Current Ratio | 27.40 |